Glyco-functionalised quantum dots and their progress in cancer diagnosis and treatment
Authors:
Open Access
- 27 September 2019
- journal article
- review article
- Published by Springer Nature in Frontiers of Chemical Science and Engineering
- Vol. 14 (3) , 365-377
Abstract
Despite all major breakthroughs in recent years of research, we are still unsuccessful to effectively diagnose and treat cancer that has express and metastasizes. Thus, the development of a novel approach for cancer detection and treatment is crucial. Recent progress in Glyconanotechnology has allowed the use of glycans and lectins as bio-functional molecules for many biological and biomedical applications. With the known advantages of quantum dots (QDs) and versatility of carbohydrates and lectins, Glyco-functionalised QD is a new prospect in constructing biomedical imaging platform for cancer behaviour study as well as treatment. In this review, we aim to describe the current utilisation of Glyco-functionalised QDs as well as their future prospective to interpret and confront cancer.Keywords
This publication has 82 references indexed in Scilit:
- Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infectionNature Communications, 2012
- Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challengesTrends in Molecular Medicine, 2010
- Nanotechnology in Medical ImagingArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Quantum Dots for In Vivo Small-Animal ImagingJournal of Nuclear Medicine, 2009
- Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsNature Materials, 2009
- Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living MiceSmall, 2009
- New Technologies for Human Cancer ImagingJournal of Clinical Oncology, 2008
- Bioconjugated quantum dots for in vivo molecular and cellular imaging☆Advanced Drug Delivery Reviews, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002